05.13.2025
Research from Vibrant Sciences, confirming high sensitivity and broad pathogen coverage using low-volume antibody testing, published in Nature
SANTA CLARA, Calif., May 13, 2025 (Newswire.com) - A new study published in Nature Scientific Reports validates the performance of a customizable multiplex protein microarray developed by Vibrant Sciences, the research arm of lab testing company Vibrant Wellness. The peer-reviewed findings confirm that the platform enables highly sensitive, simultaneous antibody detection for over 17 tickborne and related pathogens, offering a faster, more comprehensive approach to infectious disease testing.
"We designed this platform to bring scale, speed, and precision to infectious disease testing. Its high-throughput microarray format can detect dozens of pathogens at once, including bacteria, viruses, and parasites, using a single sample," said Vasanth Jayaraman, Chief Operating Officer at Vibrant. "This kind of clarity is critical for patients whose symptoms don't fit one diagnosis, and whose answers have been long delayed."
The platform supports IgG and IgM testing for Borrelia (Lyme disease) and numerous co-infections, including Babesia, Bartonella, Anaplasma, and Epstein-Barr Virus, among others.
The study included serum samples from over a dozen international collaborators across North America, Europe, and the Middle East, underscoring the platform's ability to support global testing needs. Its design allows for future expansion to cover emerging pathogens such as tularemia, relapsing fever, Rickettsia parkeri, and Heartland virus.
Study Highlights
Detects bacterial, viral, and parasitic pathogens in a single test
High IgG and IgM sensitivity and specificity, including 100% sensitivity for Powassan virus and 99-100% specificity across pathogens
Delivers comprehensive results from a single, low-volume blood sample, minimizing patient burden and simplifying lab processing
Fully automated and scalable for epidemiologic research and routine care
The approach captures both current and past infections, making it valuable for identifying co-infections or immune responses that might not be detectable through direct pathogen testing alone.
Why It Matters
Standard Lyme testing involves multi-step protocols that miss co-infections or delay care. Vibrant's platform delivers more insights in a single test, reducing cost, turnaround time, and uncertainty.
The platform was validated against gold-standard methods and showed:
100% combined IgG/IgM sensitivity for Borrelia, Babesia, and Bartonella
Accurate detection of tickborne encephalitis, West Nile virus, and HHV-6
Improved IgM sensitivity using a proprietary antibody isolation method
As tickborne infections rise globally, accurate, efficient, and scalable testing is critical. This platform provides the foundation for diagnosing current infections and adapting to tomorrow's pathogens.
The Hormone Zoomer is now available to order through the Vibrant Provider Portal! This new wet urine panel offers a deeper look into hormone metabolism, endocrine disruptors, oxidative stress, and bone health—all in one streamlined report.
The Hormone Zoomer measures 20+ adrenal hormones, 30+ sex hormones, 13 endocrine disruptors, and markers tied to oxidative stress and bone turnover.
Using clinically validated LC-MS/MS and GC-MS/MS methods, this panel supports more personalized, data-informed care.
You’ll get insights into:
Diurnal cortisol patterns and adrenal precursors
Estrogen and androgen metabolism, including methylation
Environmental toxins that may block hormone signaling
Bone degradation and oxidative stress markers tied to aging
The report includes male- and female-specific symptom questionnaires and tailored supplement suggestions to guide clinical decisions.
Read the full press release
Order the Hormone Zoomer in the Provider Portal
We know that faster results will help you provide better care and achieve improved patient outcomes. That's why we're thrilled to announce that we're now delivering results three to four days sooner for our most popular tests!
You can expect results from our Heavy Metals, Mycotoxins, Environmental Toxins, CardiaX Genetics, Toxin Genetics, Régénère Skin Care Genetics, Oxidative Stress Genetics Panel, and Gut Zoomer tests in just seven days, and our Micronutrient panel and NutriPro test in just ten days.
We’re excited to share that we’ve updated to a larger, state-of-the-art facility in Santa Clara, California! This move is a significant milestone in our mission to help you gain more insights into patient health with the most advanced precision lab tech. Our new location will better accommodate much larger volumes and enhanced automation to streamline our operations. Ultimately, this move will allow us to provide you with even better service. We appreciate your patience during this transition, as lab processing times may be slightly extended through April 10 by up to five days. Rest assured that our commitment to running your labs as accurately as possible remains unchanged. We have taken all necessary precautions to ensure this change does not affect lab safety and accuracy. We thank you for your continued support during this transition. We look forward to continuing to provide you with the highest level of service from our new facility!
We heard you wanted a more intuitive lab test reporting layout—and we listened. Over the past few months, our team has been working tirelessly to create new reports that enable you to read and interpret results easily to make the best recommendations for your patients. We’re excited to announce that it’s finally ready. This new report is designed for more straightforward interpretation and will be available for our Total Toxin panels: Heavy Metals, Mycotoxins, and Environmental Toxins.
Vibrant America, a leading provider of diagnostic testing solutions, is proud to announce that it has received approval to operate in New York State, effectively expanding its services to all 50 states across the United States. With this milestone achievement, Vibrant America solidifies its commitment to making high-quality, affordable diagnostic services accessible to every American.